Europe · Markets & Finance · BFM Bourse

Gensight biologics: GenSight Biologics finalise son augmentation de capital de 1 million d'euros

Published by BFM Bourse · France 1 d ago

(Zonebourse.com) - La société biopharmaceutique française a annoncé le règlement-livraison de sa levée de fonds d'un montant de 1 000 000,208 euros, ...

Read the full article on BFM Bourse Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingsat.com)

Also worth reading

This is Money

Are you considering buying Premium Bonds? This is the best time to snap them up - and why I expect there's good news on the way: SYLVIA MORRIS

Financial Times

Gensight biologics: GenSight Biologics finalise son augmentation de capital de 1 million d'euros

Share

Also worth reading

Are you considering buying Premium Bonds? This is the best time to snap them up - and why I expect there's good news on the way: SYLVIA MORRIS

Trump exempts Russia from further sanctions mandated by new law

These are the best literary hotels in Europe

BOJ may need to tighten faster if inflation beats forecast, IMF says

Celestia jumps 57% to 11-month high as 7 altcoins beat the market

‘It's time to stop changing the clocks twice a year’